ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 109 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,932 | -17.4% | 11,557 | 0.0% | 0.00% | – |
| Q1 2023 | $7,180 | -4.3% | 11,557 | 0.0% | 0.00% | – |
| Q4 2022 | $7,501 | -62.5% | 11,557 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $20,000 | 0.0% | 11,557 | -62.0% | 0.00% | 0.0% |
| Q1 2022 | $20,000 | -39.4% | 30,402 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $33,000 | -46.8% | 30,402 | -0.5% | 0.00% | -50.0% |
| Q3 2021 | $62,000 | -29.5% | 30,568 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $88,000 | +6.0% | 30,568 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $83,000 | -42.4% | 22,852 | -1.1% | 0.00% | -87.5% |
| Q3 2017 | $144,000 | +77.8% | 23,099 | +78.8% | 0.02% | +60.0% |
| Q2 2017 | $81,000 | +2.5% | 12,922 | -7.5% | 0.02% | 0.0% |
| Q3 2016 | $79,000 | +426.7% | 13,966 | +365.5% | 0.02% | – |
| Q4 2014 | $15,000 | -99.9% | 3,000 | 0.0% | 0.00% | -100.0% |
| Q2 2014 | $12,090,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |